- JZL 195
-
- $1.00 / 1KG
-
2020-03-06
- CAS:1210004-12-8
- Min. Order: 1KG
- Purity: 97%-99.9%
- Supply Ability: 100kg
|
| JZL 195 Basic information |
Product Name: | JZL 195 | Synonyms: | JZL 195;4-nitrophenyl 4-(3-phenoxybenzyl)piperazine-1-carboxylate;4-[(3-Phenoxyphenyl)methyl]-1-piperazinecarboxylic acid 4-nitrophenyl ester;CS-1586;JZL-195;JZL 195;JZL195;1-Piperazinecarboxylic acid, 4-[(3-phenoxyphenyl)methyl]-, 4-nitrophenyl ester;4-Nitrophenyl 4-[(3-phenoxyphenyl)methyl]-1-piperazinecarboxylate;Autophagy,Monoacylglycerol lipase,inhibit,MAGL,Fatty acid amide hydrolase,JZL-195,JZL195,Inhibitor,FAAH,JZL 195 | CAS: | 1210004-12-8 | MF: | C24H23N3O5 | MW: | 433.46 | EINECS: | | Product Categories: | Inhibitors;API | Mol File: | 1210004-12-8.mol | ![JZL 195 Structure](CAS/20180808/GIF/1210004-12-8.gif) |
| JZL 195 Chemical Properties |
Boiling point | 581.8±50.0 °C(Predicted) | density | 1.303±0.06 g/cm3(Predicted) | storage temp. | Sealed in dry,Store in freezer, under -20°C | solubility | DMSO: ≥5mg/mL at warmed | pka | 6.13±0.10(Predicted) | form | powder | color | white to beige |
Hazard Codes | N | Risk Statements | 50 | Safety Statements | 61 | RIDADR | UN 3077 9 / PGIII | WGK Germany | 3 |
| JZL 195 Usage And Synthesis |
Description | Fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) mediate the hydrolysis of the endocannabinoids arachidonoyl ethanolamide (AEA) and 2-arachidonoylglycerol (2-AG), respectively. JZL 195 is a potent inhibitor of both FAAH and MAGL (IC50s = 2 and 4 nM, respectively). It poorly inhibits neuropathy target esterase and ABHD6 and does not inhibit other brain serine hydrolases. JZL 195 displays time-dependent inhibition of FAAH and MAGL in vivo, consistent with a covalent mechanism of activation. The in vivo inhibitory actions of JZL 195 against FAAH and MAGL are comparable to those of the selective inhibitors PF-3845 and JZL 184 , respectively. Through its inhibitory actions, JZL 195 simultaneously augments brain levels of AEA and 2-AG, producing antinociceptive, cataleptic, and hypomotility effects like those produced by direct CB1 agonists. | Uses | JZL195 is a selective and efficacious dual FAAH/MAGL inhibitor with IC50 of 13 nM and 19 nM for mouse brain FAAH and MAGL respectively. | storage | Store at -20°C |
| JZL 195 Preparation Products And Raw materials |
|